The present and future role of photodynamic therapy in cancer treatment.

By S. Brown, E. A. Brown, Ian Walker. The Lancet Oncology, 2004

1,528 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Epidemiology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/a6c25b6707610b3641db78c9a5cd7015beccd785

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomedical Engineering

1. Michael S. Patterson
2. David B. Graves
3. Brian C. Wilson
4. K. Konopka
5. T. Gośliński

In Epidemiology

1. Michael S. Patterson
2. Brian C. Wilson

In Pulmonary and Respiratory Medicine

1. Michael S. Patterson
2. David B. Graves
3. Brian C. Wilson
4. K. Konopka
5. T. Gośliński

Citations in the corpus

• Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. (2009, background): “It is clear, however, that the combination of all these components in PDT is required for optimum long-term tumor regression, especially of tumors that may have metastasized [3,6,23].”
• Photophysics and photochemistry of photodynamic therapy: fundamental aspects (2009, background): “The most serious drawback of PDT as a frontline anticancer therapy lies in the fact that large, controlled, comparative, randomized clinical trials either have not been undertaken yet [59] or could not prove a significant advantage over conventional approaches [64].”
• A Review of Progress in Clinical Photodynamic Therapy (2005, background): “Review articles on past work, new aspects and future applications have been published regularly while new technology and promising applications continue to be discovered (2, 6-14).”
• The physics, biophysics and technology of photodynamic therapy (2008, methodology): “The current status has been presented in detail in recent reviews (Brown et al 2004, Maisch 2007, Mennel et al 2007).”
• The emerging role of reactive oxygen and nitrogen species in redox biology and some implications for plasma applications to medicine and biology (2012, background): “For example, Brown et al [130] noted that circa 2004, PDT had been in use for 25 years for oncology, with thousands of patients treated and considerable success in dermatological oncology and opthamology, but it had not really entered the mainstream in oncology overall.”
• Oncologic photodynamic therapy photosensitizers: a clinical review. (2010, background): “Further fluorescent signatures of malignant or premalignant lesions may be distinct enough to allow for optical diagnosis (PD) instead of histological diagnosis [36].”
• Photodynamic Therapy in Dentistry (2007, background): “Topical ALA and its esters have been used to treat pre-cancer conditions, and basal and squamous cell carcinoma of the skin (Peng et al., 1997; Brown et al., 2004).”
• EMT and tumor metastasis (2015, background): “However, as worldwide immunization campaigns evolve, cervical cancer persists as a clinical challenge, and stage IV cervical cancer is still generally considered untreatable, though chemotherapy is recommended which uses platinum drugs [103].”
• Photodynamic therapy in the treatment of microbial infections: Basic principles and perspective applications (2006, background): “Photodynamic therapy (PDT) has now obtained regulatory approval for the treatment of selected tumors in many countries, even though the total number of clinical indications is still limited [1,2].”